Bristol-Myers Squibb Co. announced on Thursday that it has changed the labeling for Tequin (gatifloxacin), an antibiotic used to treat pneumonia, bronchitis, uncomplicated gonorrhea, and infections such as urinary tract, kidneys, and skin.

The U.S. Food and Drug Administration (FDA) says the labeling changes update the prescription information as a result of continued reports of serious cases of hypoglycemia (low blood sugar) and hyperglycemia (high blood sugar) in patients receiving Tequin

Syphilis cases in the U.S. are on the rise, while gonorrhea disease rates reach a historic low.

The annual report on sexually transmitted diseases (STD) by the U.S. Centers for Disease Control and Prevention shows that although syphilis is rarer in the United States than gonorrhea and chlamydia, the rate of infection is rising primarily among men who have sex with men

Syphilis cases in the U.S. are on the rise, while gonorrhea disease rates reach a historic low.

The annual report on sexually transmitted diseases (STD) by the U.S. Centers for Disease Control and Prevention shows that although syphilis is rarer in the United States than gonorrhea and chlamydia, the rate of infection is rising primarily among men who have sex with men